Back to today’s briefing

Story perspectives

Greggs Adapts Menu Amid Surge in Appetite-Suppressing Drugs

1/9/2026

30 4

Summary

Story summary

Roisin Currie, Chief Executive Officer of Greggs plc, says appetite-suppressing medications are altering consumer behavior and prompting Greggs to introduce healthier options, including shifts toward smaller portions and more protein and fiber.
Greggs reported a 7.4% sales increase over the three months ending December 27, 2025.
Ken Murphy, Chief Executive Officer of Tesco, says the company is closely monitoring weight loss drug trends.

1 of 1

Story summary

Roisin Currie, Chief Executive Officer of Greggs plc, says appetite-suppressing medications are altering consumer behavior and prompting Greggs to introduce healthier options, including shifts toward smaller portions and more protein and fiber.
Greggs reported a 7.4% sales increase over the three months ending December 27, 2025.
Ken Murphy, Chief Executive Officer of Tesco, says the company is closely monitoring weight loss drug trends.